In a joint effort with Ricoh Americas Corporation*, BBK Worldwide, Inc., announces the expansion of its production facility to include full-service, in-house distribution services, called Distribution Central. These services were developed to reduce the time-to-market for production and distribution of communications materials to the clinical research sites.
BBK is committed to making the same robust tools currently available to study sites in the United States, available to study sites throughout the world. Distribution Central complements BBK's cultural adaptation, translation and variable in-house printing capabilities.
In addition to Distribution Central, BBK will be introducing an online document management system designed specifically to track recruitment and retention materials for clinical trials. Starting in October, BBK will be taking on full responsibility for regulatory submissions globally, and managing direct distribution to study sites on an expedited basis.
Clinical trial sponsors in need of assistance with any aspect of material development–from creative concepts, to development and production, to delivery at an investigator's doorstep–can contact BBK at (617) 630-4477 or info@bbkworldwide.com.
*Ricoh Americas Corporation is the US arm of Ricoh Company, Ltd., Japan.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.